Anlin Xu, MD
Allergy · San Jose, CANPI 1285681007
Payments from drug & device makers
Across 490 payments — averaging $32.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$3K
- Genentech USA, Inc.$2K
- Sanofi$2K
- CSL Behring$585
- Amgen$560
- plus $4K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 63 | $3,149 |
| GSK | 145 | $3,123 |
| Genentech USA, Inc. | 30 | $2,298 |
| Sanofi | 53 | $1,617 |
| CSL Behring | 30 | $585 |
| Amgen(2 entities) | 19 | $560 |
| Novartis | 18 | $536 |
| Regeneron Healthcare Solutions, Inc. | 14 | $444 |
| ARS Pharmaceuticals Operations, Inc. | 16 | $406 |
| Teva Pharmaceuticals USA, Inc. | 9 | $332 |
| Pfizer | 15 | $300 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $257 |
| Organon | 6 | $242 |
| Incyte Corporation | 6 | $231 |
| Galderma Laboratories, L.p. | 4 | $217 |
| Sun Pharmaceutical Industries Inc. | 1 | $195 |
| Alk-abello, Inc | 8 | $179 |
| AbbVie(2 entities) | 3 | $166 |
| Boehringer Ingelheim | 6 | $165 |
| Lilly USA, LLC | 4 | $99 |
| LEO Pharma Inc. | 4 | $80 |
| Grifols Shared Services North America, Inc. | 1 | $72 |
| Circassia Inc. | 2 | $65 |
| Octapharma USA, Inc. | 2 | $64 |
| Kowa Pharmaceuticals America, Inc. | 3 | $63 |
| Sanofi-aventis U.S. LLC | 3 | $62 |
| Optinose US, Inc. | 3 | $56 |
| Kaleo, Inc. | 3 | $51 |
| Grifols USA, LLC | 2 | $50 |
| Ionis Pharmaceuticals, Inc. | 1 | $40 |
| Hospira, Inc. | 1 | $26 |
| Genentech, Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $23 |
| Covis Pharma GmbH | 1 | $22 |
| USWM, LLC | 1 | $17 |
How this compares
$15,813 in reported general payments places this provider in the 80th percentile of 117 allergy providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in San Jose
- John KelloggSan Jose$17K
- Alan HellerSan Jose$10K
- Theodore ChuSan Jose$10K
- Ricardo TanLos Angeles$11.2M
- Joshua JacobsWalnut Creek$5.1M
- Warner CarrLaguna Niguel$2.4M
- William BergerMission Viejo$976K
- Robert ZeigerSan Diego$722K
- Bradley ChippsSacramento$712K
- Travis MillerRoseville$277K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.